PAEA EOC & Summative Practice | Q&A Latest 2024/2025 | 100%
PAEA EOC & Summative Practice | Q&A Latest 2024/2025 | 100% what exactly causes the occlusive vascular disease of thromboangiitis obliterans? - Answer -aka Buerger's disease inflammatory thrombi affecting the medium and small vessels (nonatherosclerosis) polymorphonuclear leukocytes, microabscesses, and multinucleated giant cells may be presen Treatment options for thromboangiitis obliterans? - Answer -smoking cessation most important! cilostazol (PDE 3 inhibitor) has vasodilator properties (alleviated symptoms) if raynauds also present, CCB (nifedipine) what heart failure treatment provides a benefit of reduction in morbidity and mortality? - Answer -ACE inhibitors beta blockers can also reduce M&M
Escuela, estudio y materia
- Institución
- PAEA
- Grado
- PAEA
Información del documento
- Subido en
- 7 de febrero de 2025
- Número de páginas
- 40
- Escrito en
- 2024/2025
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
Temas
-
paea eoc summative practice 2024
-
paea eoc summative practice 2025
-
what exactly causes the occlusive vascular disease
Documento también disponible en un lote